PDCD1 and liver cancer: We conducted a multicenter retrospective cohort study of patients with FLC who were treated with anti-PD1 or anti-PDL1 therapies using data from the Johns Hopkins Liver Cancer Database, the UT Southwestern Medical Center Liver Cancer Database, and the Fibrolamellar Registry, an international registry of patients with FLC.